Emzotamig
Based on 1 Customer Validation
Emzotamig is a monoclonal antibody inhibitor targeting tumor necrosis factor (TNF). Emzotamig is promising for research of autoimmune diseases associated with TNF overexpression, such as rheumatoid arthritis and ankylosing spondylitis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 97.35%
- CAS 番号: 3037572-57-6
- 分子量:124.59 kDa
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Isotype
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
Species Reactivity
Human
IC50 & Target
TNFRSF17 & NCR1
遺伝子ID
アクセッション番号
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized BCMA/TNFRSF17 Protein, Human (HEK293, HY-P70827) can bind Emzotamig. The ED50 for this effect is 8.653 ng/mL. -
Immobilized NKp46/NCR1 Protein, Human (HEK293, HY-P77810) can bind Emzotamig. The ED50 for this effect is 172.2 ng/mL.
化学情報
-
CAS 番号 3037572-57-6
-
性状 Liquid
-
分子量 124.59 kDa
-
Color Colorless to off-white
-
SMILES
N/A
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
-
データシート (269 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)